Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marcus Keep, Eskil ElmerfiledCriticalMarcus Keep
Priority to NZ508376ApriorityCriticalpatent/NZ508376A/en
Priority claimed from PCT/US1999/004359external-prioritypatent/WO2000050058A1/en
Publication of NZ508376ApublicationCriticalpatent/NZ508376A/en
A pharmaceutical composition comprising a concentrated solution of a cyclosporin dissolved in DMSO. The composition is suitable for cerebrospinal, intra-ocular, intravestibular, intraparenchymal or vascular application.
NZ508376A1999-02-261999-02-26Cerebrospinal and vascular pharmaceutical composition and process for preparing the same
NZ508376A
(en)
Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containingthe same.
2'-Substituted 1,1'-iphenyl-2-carbonamides, methodfor the production thereof, use thereof as medicament and pharmaceutical preparations containing said compounds.
Use of (+)-tramadol, o-demethyltramadol or (+)-o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol or (+)-o-desmethyl-n-mono-desmethyl-tramadol for treating urinary incontinence
Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
Optically active 2-aminotetraline, process for its preparation and pharmaceutical compositions containing same, active in preventing and treating septic shock